Spithoven, Edwin M2; Kramer, Anneke2; Meijer, Esther3; Orskov, Bjarne1; Wanner, Christoph2; Abad, Jose M2; Aresté, Nuria2; de la Torre, Ramón Alonso2; Caskey, Fergus2; Couchoud, Cécile2; Finne, Patrik2; Heaf, James1; Hoitsma, Andries2; de Meester, Johan2; Pascual, Julio2; Postorino, Maurizio2; Ravani, Pietro2; Zurriaga, Oscar2; Jager, Kitty J2; Gansevoort, Ron T2
1 Department of Nephrology, Herlev and Gentofte Hospital, The Capital Region of Denmark2 unknown3 Institut for Agroøkologi - Jordbrugssystemer og Bæredygtighed
prevalence and survival--an analysis of data from the ERA-EDTA Registry
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the fourth most common renal disease requiring renal replacement therapy (RRT). Still, there are few epidemiological data on the prevalence of, and survival on RRT for ADPKD. METHODS: This study used data from the ERA-EDTA Registry on RRT prevalence and survival on RRT in 12 European countries with 208 million inhabitants. We studied four 5-year periods (1991-2010). Survival analysis was performed by the Kaplan-Meier method and by Cox proportional hazards regression. RESULTS: From the first to the last study period, the prevalence of RRT for ADPKD increased from 56.8 to 91.1 per million population (pmp). The percentage of prevalent RRT patients with ADPKD remained fairly stable at 9.8%. Two-year survival of ADPKD patients on RRT (adjusted for age, sex and country) increased significantly from 89.0 to 92.8%, and was higher than for non-ADPKD subjects. Improved survival was noted for all RRT modalities: haemodialysis [adjusted hazard ratio for mortality during the last versus first time period 0.75 (95% confidence interval 0.61-0.91), peritoneal dialysis 0.55 (0.38-0.80) and transplantation 0.52 (0.32-0.74)]. Cardiovascular mortality as a proportion of total mortality on RRT decreased more in ADPKD patients (from 53 to 29%), than in non-ADPKD patients (from 44 to 35%). Of note, the incidence rate of RRT for ADPKD remained relatively stable at 7.6 versus 8.3 pmp from the first to the last study period, which will be discussed in detail in a separate study. CONCLUSIONS: In ADPKD patients on RRT, survival has improved markedly, especially due to a decrease in cardiovascular mortality. This has led to a considerable increase in the number of ADPKD patients being treated with RRT.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Vol 29 Suppl 4